Leucine-based motif and clostridial neurotoxins

Details for Australian Patent Application No. 2001280703 (hide)

Owner Allergan, Inc.

Inventors Steward, Lance E.; Herrington, Todd M.; Aoki, Kei Roger; Fernandez-Salas, Ester

Agent Davies Collison Cave

Pub. Number AU-B-2001280703

PCT Pub. Number WO02/08268

Priority 09/620,840 21.07.00 US

Filing date 20 July 2001

Wipo publication date 5 February 2002

Acceptance publication date 31 August 2006

International Classifications

C07K 14/33 (2006.01) Peptides having more than 20 amino acids

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

31 August 2006 Application Accepted

  Published as AU-B-2001280703

4 January 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001280704

2001280702-Compounds and methods for treatment and diagnosis of chlamydial infection